Area of research
Radiology, Nuclear Medicine and Imaging · Pulmonary and Respiratory Medicine
Research interest
Research interests include Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research, Peptidase Inhibition and Analysis, and Mass Spectrometry Techniques and Applications.
Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer
Bispecific PSMA-617 / RM2 Heterodimer for Theranostics Applications in Prostate Cancer
Investigation of Tumor Cells and Receptor-Ligand Simulation Models for the Development of PET Imaging Probes Targeting PSMA and GRPR and a Possible Crosstalk between the Two Receptors
PET Diagnostic Molecules Utilizing Multimeric Cyclic RGD Peptide Analogs for Imaging Integrin αvβ3 Receptors
Synthesis, characterization and evaluation of 68Ga labelled monomeric and dimeric quinazoline derivatives of the HBED-CC chelator targeting the epidermal growth factor receptor
Radiopharmaceutical Sciences
A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR
Bispecific radioligands targeting prostate‐specific membrane antigen and gastrin‐releasing peptide receptors on the surface of prostate cancer cells
Designing tracers for PET imaging of the urokinase‐type plasminogen activator receptor from a cyclic uPA‐derived peptide: first in vitro evaluations
Monomeric and Dimeric <sup>68</sup>Ga-Labeled Bombesin Analogues for Positron Emission Tomography (PET) Imaging of Tumors Expressing Gastrin-Releasing Peptide Receptors (GRPrs)
A Convenient Synthesis for HBED-CC-tris(tert-butyl ester)
Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer
Co-administration of succinylated gelatine with a 99m Tc-bombesin analogue, effects on pharmacokinetics and tumor uptake
Development of Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for PET Imaging of Prostate Cancer
Pharmacokinetic optimization of bispecific PSMA/GRPr targeting radioligands for PET imaging of prostate cancer
2015cited by 0position: first